title: Editorial Commentary: Who is "Special" Now?
authors.affiliation: Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
authors.forename: Ashwin
authors.initials: A
authors.lastname: Balagopal
authors.affiliation: Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
authors.forename: David L
authors.initials: DL
authors.lastname: Thomas
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D060085:Coinfection / Q000821:virology*; D005260:Female; D015658:HIV Infections / Q000150:complications*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male
chemical_list: D000998:Antiviral Agents; D007093:Imidazoles
keywords: HIV/HCV coinfection; cirrhosis; direct-acting antivirals; hepatitis C virus; interferon